The catalysts you referred to might not have occurred in the originally expected timeframe, but they are still out there to be achieved in the near term. The studies and trials involving things in the AMBS pipeline haven't failed...they have just been delayed. By all indications, things are still on track. They haven't scrapped anything or changed their plan. Too many people make it sound like there have been failed trials and major failures in the pipeline. I've been in small biotechs who didn't meet end points in phase 2 and 3 trials. That's real disappointment. That's not the case here. People whine that GC hasn't delivered. It's not that he won't or can't deliver, it's just that he hasn't delivered yet for a variety of reasons. Let it play out. We've waited this long. I'm not typically one to say, "sell your shares and move on," but if you really don't trust management, why would you stay? I don't think anything has changed fundamentally for the negative. You may disagree and that's fine. That's why we use this forum.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links